Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform. Its lead produc...
Q2 2026
Aug 11, 2026
Q1 2026
May 6, 2026
FY 2025
Mar 9, 2026
Q4 2025
Q3 2025
Nov 5, 2025